Literature DB >> 26041399

Radix Astragali and Tanshinone Help Carboplatin Inhibit B16 Tumor Cell Growth.

Jinyi Wu1, Haiming Xu1, Lei Zhang2, Xiuying Zhang3.   

Abstract

BACKGROUND: Excessive UV radiation causes increased melanoma incidence. Postoperation chemotherapy will destroy lymphocytes and compromise immune response. Immunodepression is also detected in patients with cancers. Previous studies suggested that polysaccharide-protein complexes manifested immunomodulatory and antitumor activities. Radix Astragali (RA) extract is a product of polysaccharide-protein complexes, which has been used in the treatment of a variety of diseases because of its low toxicity to the host. Tanshinone (TA) is a derivative of phenanthrenequinone isolated from Danshen, which is suggested to inhibit tumor growth by inducing apoptosis in tumor cells. Carboplatin (CA) is a commonly used chemotherapeutic drug in melanoma treatment. Therefore, we hypothesized that the combination of RA and TA will help CA better inhibit the B16 cell growth.
PURPOSE: The study will test that the efficacy of growth inhibition of tumor cell produced by CA + RA + TA is better than CA + RA or CA + TA.
METHODS: The B16 tumor cells were injected to Swiss-Hauschka (ICR) mice subcutaneously. Twenty-four hours later, mice received CA intraperitoneally, CA + RA (RA were administered gastrically at the dosage of 10 g/kg body weight), CA + TA (TA were administered gastrically at the dosage of 0.5 g/kg body weight), or no treatment (model group). Tumor weight, volume, latency, incidence, the percentage of CD4(+) and CD8(+) in spleen, and natural killer (NK), and cytotoxic lymphocyte (CTL) activities were measured and compared among different groups.
RESULTS: Compared with mice treated with CA + RA, CA + TA, or CA alone, the mice treated with CA + RA + TA showed (1) significantly smaller tumor weight and tumor volume; (2) significantly longer tumor latency; (3) significantly lower tumor incidence; and (4) significantly increased percentage of CD4(+) and CD8(+) in spleen and increased activities of NK and CTL.
CONCLUSION: Combination of RA and TA can help CA produce more effective inhibition on B16 cell growth.
© The Author(s) 2015.

Entities:  

Keywords:  B16; Radix Astragali; Tanshinone; immunomodulation; tumor treatment

Mesh:

Substances:

Year:  2015        PMID: 26041399     DOI: 10.1177/1533034615588682

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  3 in total

1.  Expression of mutant p53 in oral squamous cell carcinoma is correlated with the effectiveness of intra-arterial chemotherapy.

Authors:  Yadong Li; Jinsong Zhang
Journal:  Oncol Lett       Date:  2015-08-27       Impact factor: 2.967

Review 2.  Astragalus polysaccharide: a review of its immunomodulatory effect.

Authors:  Chun-Xiao Li; Ying Liu; Yu-Zhen Zhang; Jing-Chun Li; Jiang Lai
Journal:  Arch Pharm Res       Date:  2022-06-17       Impact factor: 4.946

Review 3.  Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes.

Authors:  Meng Lu; Xintian Lan; Xi Wu; Xiaoxue Fang; Yegang Zhang; Haoming Luo; Wenyi Gao; Donglu Wu
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.